⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Product for Rare/Orphan Diseases"
prnewswire.com
ALNY
ARQT
IONS
JAZZ
JNJ
MRK
PFE
AKBA
ARDX
BMY
BIIB
GILD
INSM
NVS
AGIO
BBIO
CRNX
GERN
KAVL
Next Generation Drug Conjugates Market Report (2nd Edition) | Trends, Strategies and Sales Forecast 2026-2035
globenewswire.com
NVS
NVO
AZN
Biopharmaceutical Contract Manufacturing Market (7th Edition) Now Available - Maps Manufacturing Capacity and Regulatory Dynamics Across 25+ Countries Over 2026-2035
globenewswire.com
ABBV
CAT
NVS
Global Cancer Immunotherapy Market Report 2026 | Industry to Reach $311.43 Billion by 2031, Driven by Precision Oncology and Cell Therapy Innovation
globenewswire.com
AMGN
AZN
BMY
MRK
PFE
NVS
GSK
LLY
ABBV
JNJ
REGN
SNY
BE
BNTX
MRNA
IOVA
Global Regenerative Medicine Market is Projected to Cross the USD 160 Billion Mark by 2034 | DelveInsight
globenewswire.com
NVS
BBIO
PTC
BMRN
SAVA
PFE
CAT
TMO
LH
VERI
INCY
GILD
MRK
REGN
JAZZ
CELU
OMER
Global Regenerative Medicine Market is Projected to Cross the USD 160 Billion Mark by 2034 | DelveInsight
globenewswire.com
NVS
BBIO
CSL
BMRN
PFE
LNZA
TMO
MRK
CYN
INCY
GSK
JAZZ
GILD
CELU
OMER
FOUNDATION CONSUMER HEALTHCARE ANNOUNCES SENIOR LEADERSHIP CHANGES FOLLOWING STRATEGIC REPOSITIONING INTO WOMEN'S HEALTH
prnewswire.com
HLN
NVS
MDT
Aravax Awarded FDA Fast Track Designation for PVX108, a Next-Generation Immunotherapy for the Treatment of Peanut Allergy
globenewswire.com
NVS
Ratio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development of Targeted Radiotherapeutics Pipeline and Expand Manufacturing Infrastructure
prnewswire.com
BMY
LLY
NVS
Questex’s Fierce Pharma announces launch of Fierce Pharma Week Europe in Basel, Switzerland in June 2027
globenewswire.com
NVS